Effects of azilsartan: A Synthesis of Findings from 17 Studies
- Home
- Effects of azilsartan
This analysis is based on research papers included in PubMed, but medical research is constantly evolving and may not fully reflect the latest findings. There may also be biases towards certain research areas.
This information is not medical advice and is not a substitute for diagnosis or treatment by a physician. If you have concerns about "Effects of azilsartan: A Synthesis of Findings from 17 Studies", please consult your doctor.
For NLM copyright information, please see Link to NLM Copyright Page
PubMed data is obtained via Hugging Face Datasets: Link to DatasetPlease check the disclaimer.
Major Research Findings
Azilsartan is an angiotensin II receptor blocker (ARB) used to treat high blood pressure. These research articles investigate azilsartan's effectiveness in lowering blood pressure and potential benefits in treating various conditions such as diabetes and heart failure.
Azilsartan demonstrated comparable efficacy to other ARBs, olmesartan and valsartan, in managing blood pressure among patients with type 2 diabetes, as reported in 16 . Additionally, 10 suggests that azilsartan might be effective in improving left ventricular diastolic function in patients with heart failure with preserved ejection fraction.
Azilsartan has been shown to prevent or reverse cerebrovascular remodeling associated with diabetes by improving blood vessel wall thickness and contractility, as indicated by 17 . Moreover, 7 demonstrates azilsartan's ability to inhibit endothelial dysfunction and inflammation linked to the development of atherosclerosis.
Azilsartan effectively lowers blood pressure and reduces urinary albumin excretion compared to other ARBs, as reported in 11 . Azilsartan may also be beneficial in improving insulin resistance in diabetic patients. 4 suggests that azilsartan may have superior insulin resistance improvement compared to telmisartan.
Azilsartan exhibits cardioprotective effects in an in vivo model of myocardial ischemia-reperfusion injury, as reported in 6 . This research indicates that azilsartan may exert cardioprotective benefits through its antioxidant, anti-apoptotic, anti-inflammatory, mitogen-activated protein kinase (MAPK) modulation, and peroxisome proliferator-activated receptor gamma (PPAR-γ) agonist activities.
Azilsartan improves the effects of etanercept, a rheumatoid arthritis treatment, in patients with active rheumatoid arthritis, as reported in 9 . These research findings indicate that azilsartan could be a promising drug in treating high blood pressure.
Benefits and Risks
Benefit Summary
Azilsartan may be an effective medication for managing high blood pressure. It effectively lowers blood pressure and might have potential benefits in treating conditions such as diabetes and heart failure. Azilsartan can also help prevent or reverse cerebrovascular remodeling associated with diabetes and potentially inhibit endothelial dysfunction and inflammation. Additionally, azilsartan may offer superior insulin resistance improvement compared to other ARBs. Azilsartan also demonstrates cardioprotective effects and has been shown to enhance the effectiveness of etanercept, a rheumatoid arthritis treatment.
Risk Summary
Azilsartan, like other ARBs, can cause side effects. Side effects may include dizziness, lightheadedness, fatigue, headache, and digestive issues. Most of these side effects are mild and don't require stopping treatment. However, individuals with kidney or liver problems should use azilsartan with caution. Azilsartan is not recommended for pregnant or breastfeeding women. It is crucial to consult a healthcare professional when considering azilsartan use.
Comparison Between Studies
Commonalities
These studies consistently suggest that azilsartan holds promise as a medication for managing high blood pressure. The research investigated azilsartan's effectiveness in lowering blood pressure and explored its potential benefits in treating various conditions like diabetes, heart failure, cerebrovascular remodeling, endothelial dysfunction, and inflammation.
Differences
These studies employed different research designs, participant populations, and methodologies. For example, 16 focused on a clinical trial involving patients with diabetes, while 10 conducted a clinical trial involving patients with heart failure with preserved ejection fraction. Additionally, 17 conducted an animal study to assess the effects of azilsartan on preventing or reversing cerebrovascular remodeling associated with diabetes. Furthermore, 7 utilized in vitro experiments to investigate azilsartan's impact on endothelial dysfunction and inflammation.
Consistency and Contradictions in Findings
These research articles indicate that azilsartan may have comparable efficacy to other ARBs in managing high blood pressure. However, further studies are necessary to determine if azilsartan is more effective or safer than other ARBs. Long-term safety and efficacy of azilsartan also require further investigation.
Implications for Everyday Life
Azilsartan could be an effective medication for managing high blood pressure. However, it is essential to remember that azilsartan, like other ARBs, can cause side effects. Most side effects are mild, but patients with kidney or liver issues should use azilsartan with caution. Azilsartan is not recommended for pregnant or breastfeeding women. Consulting a healthcare professional is crucial when considering azilsartan use.
Limitations of Current Research
These studies have certain limitations. Many are relatively small-scale trials, requiring further investigation for long-term safety and efficacy. The studies often focus on specific racial or ethnic groups, raising questions about generalizability to other populations.
Future Research Directions
Large-scale clinical trials are needed to evaluate the long-term safety and efficacy of azilsartan. Comparative studies of azilsartan with other ARBs are necessary, as are research investigations into azilsartan's effectiveness in treating various diseases. Further research should also focus on determining optimal dosages and administration methods for azilsartan.
Conclusion
Azilsartan holds promise as a medication for managing high blood pressure. These studies explored azilsartan's effectiveness in lowering blood pressure and its potential benefits in treating conditions like diabetes, heart failure, cerebrovascular remodeling, endothelial dysfunction, and inflammation. However, further investigation into the long-term safety and efficacy of azilsartan is necessary. It is important to consult a healthcare professional before considering azilsartan use.
Benefit Keywords
Risk Keywords
Article Type
Author: HarrellRobert E, KarimAziz, ZhangWencan, DudkowskiCaroline
Language : English
Author: KarioKazuomi, HoshideSatoshi
Language : English
Author: ShigaYuhei, MiuraShin-Ichiro, MotozatoKota, NorimatsuKenji, YanoMasaya, HitakaYuka, AdachiSen, KuwanoTakashi, InoueKen, InoueAsao, FujisawaKazuaki, ShirotaniTetsuro, KusumotoTakaaki, IdeishiMunehito, SakuKeijiro
Language : English
Author: NaruseMitsuhide, KoikeYasuhiro, KameiNozomu, SakamotoRyuichi, YambeYuko, ArimitsuMichinori
Language : English
Author: MeherBikash R, MohantyRashmi R, SahooJyoti P, JenaMonalisa, SrinivasanAnand, PadhyBiswa M
Language : English
Author: GargShanky, KhanSana Irfan, MalhotraRajiv Kumar, SharmaManish Kumar, KumarManoj, KaurPunit, NagTapas Chandra, RayRuma, BhatiaJagriti, AryaDharamvir Singh
Language : English
Author: WeiGuoqian, ZhuDayong, SunYongtao, ZhangLan, LiuXian, LiMing, GuJinxia
Language : English
Author: NaruseMitsuhide, KoikeYasuhiro, KameiNozomu, SakamotoRyuichi, YambeYuko, ArimitsuMichinori
Language : English
Author: MahmoodNaza Mohammed Ali, HussainSaad Abdulrahman, MirzaRaouf Rahim
Language : English
Author: TakahamaHiroyuki, AsakuraMasanori, AbeYukio, AjiokaMasayoshi, AonumaKazutaka, AnzaiToshihisa, HayashiTakaharu, HiramitsuShinya, KawaiHiroya, KiokaHidetaka, KimuraKazuo, LimYoung-Jae, MatsuokaKen, MotokiHirohiko, NagataYoji, NakamuraSunao, OhteNobuyuki, OzakiYukio, SasaokaTaishi, TamakiShunsuke, HamasakiToshimitsu, KitakazeMasafumi,
Language : English
Effects of Olmesartan and Azilsartan on Albuminuria and the Intrarenal Renin-Angiotensin System.
Author: TakamiTakeshi, OkadaSadanori, SaitoYoshihiko, NishijimaYoko, KoboriHiroyuki, NishiyamaAkira
Language : English
Author: RakugiHiromi, ShimizuKohei, SanoYuhei, NishiyamaYuya, KinugawaYoshinobu, TerashioSouhei
Language : English
Author: HussainSaad Abdulrahman, UtbaRabab Mohammed, AssumaidaeeAjwad Muhammad
Language : English
Author: GeorgiopoulosGeorgios, KatsiVasiliki, OikonomouDimitrios, VamvakouGeorgia, KoutliEvangelia, LainaAggeliki, TsioufisConstantinos, NihoyannopoulosPetros, TousoulisDimitrios
Language : English
Author: SezaiAkira, OsakaShunji, YaoitaHiroko, ArimotoMunehito, HataHiroaki, ShionoMotomi, SakinoHisakuni
Language : English
Author: WhiteWilliam B, CuadraRené H, LloydEric, BakrisGeorge L, KupferStuart
Language : English
Author: AbdelsaidMohammed, CouchaMaha, ErgulAdviye
Language : English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.